IDO1 program (NTRC)

N/A

Report date: 2025/03/20 14:49:46
NME

Base Information

Drug NameIDO1 program (NTRC)
Drug Alias Nameindoleamine pyrrole 2 3-dioxygenase 1 checkpoint inhibitors (NTRC)IDO checkpoint inhibitor (NTRC)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossfire Oncology BV
China Registration ClassN/A

Develop Information

Active CompaniesCrossfire Oncology BV
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A